PrognomiQ
Led full lifecycle development of a novel early-stage lung cancer LDT, directed CLIA/CAP readiness efforts, deployed a customized LIMS supporting the end-to-end diagnostic workflow, and helped operationalize large-scale multi-omics and laboratory programs.